Author:
Kennedy Glen A.,Tey Siok-Keen,Cobcroft Ralph,Marlton Paula,Cull Gavin,Grimmett Karen,Thomson Damien,Gill Devinder
Reference16 articles.
1. Rituximab (ICEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma;Berinstein;Annals of Oncology,1998
2. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study;Coiffier;Blood,1998
3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma;Coiffier;New England Journal of Medicine,2002
4. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with low tumor burden: clinical and molecular evaluation;Colombat;Blood,2001
5. Therapy of B-cell lymphoma with anti-CD20 antibodies can result in loss of CD20 antigen expression;Davis;Clinical Cancer Research,1999
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献